We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pre-market futures are in the red this morning, following a Monday trading session that saw major indexes move up roughly have a percentage point. At this hour, the Dow is down -226 points, -0.47%, the S&P 500 is -37 points, -0.56%, the Nasdaq -181 points, -0.75% and the small-cap Russell 2000 -19, -0.78%.
Durable Goods Orders Mixed-to-Lower in February
Preliminary Durable Goods Orders for the month of February (delayed — final results due in a couple weeks) came in lower than expected on headline, with spots of better news “beneath the fold.” Today’s -1.4% is the weakest month of Durable Goods Orders since October of last year, and 30 basis points (bps) lower than expectations. The prior month’s originally reported 0.0% ratchets down to -0.5%.
Stripping out Transportation costs, we see this figure more than double month over month to +0.8%, from a downwardly revised +0.3% in January. This is the strongest print since December of 2025. Non-defense, ex-aircraft — a proxy for “normal” business spending (computers, office space, cybersecurity, etc.) — came in better than expected at +0.6%. That said, the prior month’s “normal” business spending dropped notable to -0.4% from +0.8% originally reported.
Shipments also posted their strongest month since December: +0.9%. Of course, we’re looking in the rearview mirror here, and until we see March figures we won’t even be scratching the surface on durable goods orders that reflects realities of spiking oil prices due to the Iran war.
What to Expect from the Market Today
All eyes are on this latest deadline ultimatum from President Trump, who has given Iran until this evening to open the Strait of Hormuz — where 20% of daily global oil is transported — or be subjected to massive bombing of Iranian infrastructure ("A whole civilization will die tonight..." begins Trump's latest social media post). Should the Strait suddenly open up today, we can expect a big rally and a drop in oil prices. Should the fresh wave of bombing ensue, we’re likely to see oil prices move quite the other direction.
At this stage, WTI spot prices are up +2.4% to around $115 per barrel (/bbl), while Brent remains trailing somewhat at $110/bbl (+0.7%). Extended attacks on Iranian bridges and water desalination plants will likely bring counter-bombing to energy infrastructures in neighboring Middle Eastern countries by Iran. This would likely make the closure of the Strait of Hormuz slightly less relevant — if there is less energy to collect from the region, they won’t need to ship as much, anyway.
So markets are hedging slightly to the downside on this prospect. With earnings reports on deck for next week and beyond, what happens tonight in Iran will be greatly informative toward corporate projections toward future earnings. We’ve already seen oil prices double from the start of the year; prolonged aggravation of global oil supply and delivery will eventually find its way into virtually every company’s forward balance sheet.
We cover more than 1,000 of the most widely followed stocks in our Equity Research Reports. Each report features independent research from our analysts and provides in-depth analysis on a company, its fundamentals and its growth prospects. Quickly access reports for New Upgrades and New Downgrades.
You can also find a report on the ticker of your choice, or access all of the stock reports covered by Zacks analysts.
Popular’s revenue growth is supported by a rise in NII. An increase in loans and deposit balances strengthens its balance sheet. Steady capital distributions are aided by solid liquidity.
Cencora’s specialty expansion and GLP-1 demand fuel strong revenue growth, while robust free cash flow and scale position it to capture secular healthcare market tailwinds.
NXP's diversified product portfolio is a key catalyst. Its leading market position and focus on acquisitions and technological partnerships are major positives.
HSBC’s robust capital position and its business simplification and streamlining initiatives, will likely drive growth across the Asia region. An efficient global network is the supporting tailwind.
Increasing patient volumes, organic and inorganic growth initiatives, growing demand, cash-generating abilities and favorable ROIC are the major tailwinds for Encompass Health.
Archer Daniels has been actively managing productivity and innovation as well as aligning work to the interconnected trends in food security, health and wellbeing.
Continuous new business wins, improving IT spending, strength in the Hyve business division, global expansion, partnerships, strong cash flow and an aggressive shareholder return policy are positives.
Tapestry’s growth drivers include engagement with consumers, creating innovative and compelling products, venturing into under-penetrated markets and enhancement of omni-channel capabilities.
Supply chain issues, as well as the imposition of tariffs on imports, remain concerns for this stock. Expanded sanctions targeting the aerospace sector also pose a risk to RTX’s operations.
Weak demand may hurt the company's volumes. It is also exposed to headwinds from higher energy and input costs. Weaker prices may also weigh on margins.
Ares Management’s rising expenses and weak liquidity position may pressure near-term profitability. Further, its return on equity compares unfavorably with the industry average, remains a concern.
Pharma budget uncertainty and customer concentration limit visibility, while AI investment and legal exposure could compress margins and sentiment further.
American Eagle is well placed on cost-reduction efforts and brand progress. In the second half, the company expects to cycle tariffs and advertising investments.
Broadcom is a leading player in the semiconductor market based on its expanding product portfolio, multiple target markets, accretive acquisitions and strong cash flow.
Strength in the Energy Generation/Storage business, balance sheet strength, and focus on autonomous driving, robotics and artificial intelligence are set to drive Tesla.
AT&T is witnessing early momentum in its core market areas driven by strength in 5G and fiber, as it aims to better harness edge computing capabilities with core business focus.
Amgen’s key medicines like Evenity and Repatha as well as newer medicines like Tavneos and Tezspire are driving sales, more than offsetting declining revenues from oncology biosimilars and legacy established products such as Enbrel
Intel’s leading position in PC market, strength in servers, growing clout in software, IoT & ADAS domains and headway in process technology are positive indicators of future growth prospects.